ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

MGTX MeiraGTx Holdings PLC

5.065
0.065 (1.30%)
Fuera de horario
Última actualización: 15:00:01
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
MeiraGTx Holdings PLC MGTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.065 1.30% 5.065 15:00:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.06 4.95 5.13 5.065 5.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:30GLOBEMeiraGTx to Participate in Upcoming Investor Conferences
18/4/202415:30GLOBEMeiraGTx Announces Oral Presentation at the 2024 American..
14/3/202407:30GLOBEMeiraGTx Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202407:10EDGAR2Form 8-K - Current report
13/2/202407:00GLOBEMeiraGTx Announces $50 Million Milestone from Janssen..
09/2/202409:10EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
17/1/202418:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202307:30EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202306:10EDGAR2Form 8-K - Current report
21/12/202306:00GLOBEMeiraGTx Announces Asset Purchase Agreement Involving its..
21/11/202315:30GLOBEMeiraGTx to Participate in Upcoming Investor Conferences
14/11/202307:00GLOBEMeiraGTx Announces Third Quarter 2023 Financial and..
30/10/202307:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
30/10/202306:37EDGAR2Form 8-K - Current report
30/10/202306:30GLOBEMeiraGTx Announces $30 Million Strategic Investment from..
24/10/202307:30GLOBEMeiraGTx Announces an Oral Presentation and Eight Posters at..
10/8/202307:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:13EDGAR2Form 8-K - Current report
10/8/202307:00GLOBEMeiraGTx Reports Second Quarter 2023 Financial and..
03/8/202316:27EDGAR2Form S-3 - Registration statement under Securities Act of..
03/8/202316:22EDGAR2Form S-3 - Registration statement under Securities Act of..
01/8/202308:10GLOBEMeiraGTx Announces Poster Presentation at the 2023 American..
19/7/202307:30GLOBEMeiraGTx Announces its Wholly-Owned Gene Therapy..
27/6/202306:30GLOBEMeiraGTx Announces Positive Clinical Data from the AQUAx..
22/6/202315:01GLOBEMeiraGTx to Present 12-month Data from All Cohorts of the..
16/5/202308:00GLOBEMeiraGTx Announces the Presentation of Nine Posters at the..
11/5/202307:00GLOBEMeiraGTx Reports First Quarter 2023 Financial and..

Su Consulta Reciente

Delayed Upgrade Clock